Optimizing CMV prevention after allogenic hematopoietic stem cell transplantation: using CMV-specific cellular immunity to guide letermovir prophylaxis. [PDF]
Zhen S, Chen X, Feng S.
europepmc +1 more source
Phenotypes of cytomegalovirus genetic variants encountered in a letermovir clinical trial illustrate the importance of genotyping validation [PDF]
Sunwen Chou, J Watanabe
openalex +1 more source
580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era [PDF]
Joseph Sassine +8 more
openalex +1 more source
Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCT. [PDF]
Duplessix T +12 more
europepmc +1 more source
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [PDF]
Bruno, B. +7 more
core +1 more source
CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization [PDF]
Hannah Cherniawsky +21 more
openalex +1 more source
1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience [PDF]
Phaedon D. Zavras +8 more
openalex +1 more source
Efficacy and safety of letermovir for cytomegalovirus prophylaxis in thoracic organ transplantation: a systematic review and meta-analysis. [PDF]
Aldalati AY +8 more
europepmc +1 more source

